A recent study from Assistant Professor Joshua Niznik, PhD, PharmD, Division of Geriatric Medicine, in the Journal of American Geriatrics Society suggests de-prescribing Acetylcholinesterase Inhibitors (AChEls) as a reasonable approach to lowering polypharmacy and risk of serious falls or fractures without increasing risk for all-cause negative events in nursing home residents with severe dementia.
Co-authors included Laura Hanson, MD, MPH, Division of Geriatric Medicine, Carolyn Thorpe, PhD, MPH, Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, and Josh Thorpe, PhD, MPH, Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy.